Clinical data for blood pressure
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring clinical data for blood pressure measurements obtained via invasive arterial line, paired with companion data from pressure cuffs and wearable sensors, with solicitation release estimated for May 1, 2027 and award targeted for July 1, 2027. The arterial line data will serve as the gold-standard dataset for future validation of wearable devices and has been requested by OPEQ.
The estimated award value ranges from $250,000 to $700,000. Interested parties should direct inquiries to cdhracquisitions@fda.hhs.gov.
Forecast text
BPID: 925 - This is for a new contract to obtain clinical data for blood pressure via invasive arterial line with companion data from pressure cuffs and wearable sensors. The arterial line data will be the gold-standard dataset for future validation of wearables and requested by OPEQ to be obtained.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast